Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neisseria meningitidis | 7 | 2019 | 229 | 3.61 | Why? |
| Meningococcal Infections | 7 | 2019 | 216 | 2.81 | Why? |
| Meningitis, Meningococcal | 6 | 2019 | 114 | 2.41 | Why? |
| Neisseria gonorrhoeae | 5 | 2019 | 142 | 2.19 | Why? |
| Whooping Cough | 6 | 2019 | 201 | 2.13 | Why? |
| Bordetella pertussis | 6 | 2019 | 117 | 1.82 | Why? |
| Bacterial Capsules | 2 | 2019 | 39 | 1.53 | Why? |
| Meningococcal Vaccines | 4 | 2019 | 225 | 1.47 | Why? |
| Neisseria meningitidis, Serogroup C | 2 | 2018 | 46 | 1.46 | Why? |
| Poliovirus | 2 | 2018 | 109 | 1.31 | Why? |
| Gonorrhea | 3 | 2018 | 315 | 1.16 | Why? |
| Serogroup | 6 | 2019 | 510 | 1.10 | Why? |
| Poliomyelitis | 2 | 2018 | 263 | 1.03 | Why? |
| Antigens, Bacterial | 4 | 2019 | 330 | 0.89 | Why? |
| Pertussis Vaccine | 3 | 2019 | 89 | 0.84 | Why? |
| Neisseria meningitidis, Serogroup W-135 | 1 | 2019 | 8 | 0.79 | Why? |
| Pertussis Toxin | 2 | 2019 | 19 | 0.77 | Why? |
| Hospital Records | 1 | 2018 | 55 | 0.76 | Why? |
| Penicillinase | 1 | 2018 | 3 | 0.74 | Why? |
| Bisexuality | 1 | 2018 | 119 | 0.69 | Why? |
| Anti-Bacterial Agents | 11 | 2019 | 10083 | 0.68 | Why? |
| Microbiology | 1 | 2018 | 134 | 0.63 | Why? |
| Transients and Migrants | 4 | 2021 | 1468 | 0.62 | Why? |
| Poliovirus Vaccine, Oral | 1 | 2017 | 95 | 0.62 | Why? |
| Microbial Sensitivity Tests | 7 | 2019 | 2886 | 0.59 | Why? |
| Multilocus Sequence Typing | 5 | 2019 | 264 | 0.57 | Why? |
| Whole Genome Sequencing | 4 | 2020 | 3239 | 0.56 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.54 | Why? |
| Italy | 22 | 2021 | 38444 | 0.53 | Why? |
| Antibodies, Bacterial | 1 | 2017 | 510 | 0.52 | Why? |
| Enterovirus Infections | 1 | 2018 | 404 | 0.51 | Why? |
| Disease Outbreaks | 5 | 2019 | 27595 | 0.49 | Why? |
| Sewage | 1 | 2018 | 591 | 0.49 | Why? |
| Drug Resistance, Bacterial | 3 | 2019 | 1414 | 0.48 | Why? |
| Epidemiological Monitoring | 3 | 2018 | 3493 | 0.43 | Why? |
| Refugees | 2 | 2017 | 809 | 0.41 | Why? |
| Carrier State | 2 | 2019 | 2100 | 0.40 | Why? |
| Serotyping | 3 | 2018 | 154 | 0.40 | Why? |
| Sentinel Surveillance | 1 | 2017 | 1093 | 0.39 | Why? |
| Homosexuality, Male | 1 | 2018 | 1158 | 0.38 | Why? |
| Population Surveillance | 4 | 2020 | 4967 | 0.36 | Why? |
| Communicable Diseases | 3 | 2018 | 2148 | 0.33 | Why? |
| Sequence Analysis, DNA | 4 | 2019 | 2830 | 0.31 | Why? |
| Phylogeny | 8 | 2021 | 13341 | 0.30 | Why? |
| Penicillins | 1 | 2007 | 132 | 0.30 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.30 | Why? |
| DNA, Bacterial | 3 | 2019 | 835 | 0.29 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2018 | 1115 | 0.28 | Why? |
| Mediterranean Sea | 2 | 2021 | 88 | 0.28 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.28 | Why? |
| Rifampin | 1 | 2007 | 276 | 0.28 | Why? |
| Sicily | 2 | 2021 | 153 | 0.28 | Why? |
| Infant | 9 | 2021 | 30274 | 0.24 | Why? |
| Infant, Newborn | 6 | 2019 | 23105 | 0.23 | Why? |
| Travel | 2 | 2021 | 7220 | 0.23 | Why? |
| Europe | 9 | 2021 | 12702 | 0.22 | Why? |
| Genome, Viral | 2 | 2021 | 13157 | 0.22 | Why? |
| Adolescent | 12 | 2021 | 86841 | 0.21 | Why? |
| Libya | 1 | 2021 | 267 | 0.21 | Why? |
| Young Adult | 12 | 2020 | 93724 | 0.20 | Why? |
| Genotype | 4 | 2019 | 4697 | 0.20 | Why? |
| Virulence Factors, Bordetella | 1 | 2019 | 14 | 0.20 | Why? |
| Meningitis, Haemophilus | 1 | 2018 | 12 | 0.20 | Why? |
| Molecular Epidemiology | 3 | 2020 | 1638 | 0.20 | Why? |
| Meningitis, Pneumococcal | 1 | 2018 | 35 | 0.19 | Why? |
| Neisseria meningitidis, Serogroup B | 1 | 2019 | 66 | 0.18 | Why? |
| Haemophilus Infections | 1 | 2018 | 69 | 0.18 | Why? |
| Genome, Bacterial | 2 | 2019 | 446 | 0.18 | Why? |
| Tetanus | 1 | 2018 | 61 | 0.18 | Why? |
| Serbia | 1 | 2018 | 227 | 0.18 | Why? |
| Diphtheria | 1 | 2018 | 74 | 0.17 | Why? |
| Bosnia and Herzegovina | 1 | 2017 | 97 | 0.17 | Why? |
| Humans | 43 | 2021 | 930598 | 0.17 | Why? |
| Point Mutation | 1 | 2020 | 481 | 0.16 | Why? |
| Genitalia | 1 | 2017 | 98 | 0.16 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.16 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.15 | Why? |
| Genotyping Techniques | 1 | 2019 | 360 | 0.15 | Why? |
| Male | 20 | 2021 | 367725 | 0.15 | Why? |
| Immunization Programs | 2 | 2018 | 2006 | 0.14 | Why? |
| Incidence | 5 | 2020 | 25622 | 0.14 | Why? |
| Female | 19 | 2021 | 380317 | 0.14 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.14 | Why? |
| Epidemiologic Methods | 1 | 2018 | 392 | 0.14 | Why? |
| Plasmids | 1 | 2018 | 840 | 0.14 | Why? |
| Virulence Factors | 1 | 2017 | 338 | 0.13 | Why? |
| Adult | 14 | 2021 | 244371 | 0.13 | Why? |
| Encephalitis | 1 | 2021 | 797 | 0.13 | Why? |
| Polymerase Chain Reaction | 2 | 2019 | 6740 | 0.13 | Why? |
| Macrolides | 1 | 2017 | 369 | 0.13 | Why? |
| Vaccination | 5 | 2018 | 19050 | 0.12 | Why? |
| Dendritic Cells | 1 | 2021 | 1330 | 0.12 | Why? |
| Disease Notification | 1 | 2018 | 639 | 0.12 | Why? |
| Luminescent Measurements | 1 | 2017 | 924 | 0.12 | Why? |
| Orthomyxoviridae | 1 | 2021 | 1168 | 0.12 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.12 | Why? |
| Africa | 1 | 2021 | 2986 | 0.11 | Why? |
| Child | 7 | 2021 | 70012 | 0.11 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.11 | Why? |
| beta-Lactamases | 1 | 2018 | 759 | 0.11 | Why? |
| Pharynx | 1 | 2019 | 1544 | 0.11 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.11 | Why? |
| Virulence | 1 | 2018 | 2172 | 0.11 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.11 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.10 | Why? |
| Limit of Detection | 1 | 2018 | 2698 | 0.10 | Why? |
| Bacterial Proteins | 1 | 2019 | 1318 | 0.10 | Why? |
| Phenotype | 2 | 2021 | 4037 | 0.10 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.09 | Why? |
| Basic Reproduction Number | 1 | 2020 | 2676 | 0.09 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.09 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.09 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.09 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.09 | Why? |
| Public Health Surveillance | 2 | 2018 | 3129 | 0.09 | Why? |
| Penicillin Resistance | 1 | 2007 | 15 | 0.09 | Why? |
| Genetic Variation | 2 | 2019 | 3919 | 0.09 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.08 | Why? |
| Cities | 1 | 2018 | 4937 | 0.08 | Why? |
| Environmental Monitoring | 1 | 2018 | 3143 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 7868 | 0.07 | Why? |
| Aged | 8 | 2021 | 215776 | 0.07 | Why? |
| Cerebrospinal Fluid | 1 | 2007 | 234 | 0.07 | Why? |
| Attitude to Health | 1 | 2018 | 2002 | 0.07 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.07 | Why? |
| Germany | 1 | 2020 | 9196 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.07 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.06 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2017 | 3388 | 0.06 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.06 | Why? |
| DNA Primers | 1 | 2007 | 1170 | 0.06 | Why? |
| Glial Fibrillary Acidic Protein | 1 | 2021 | 138 | 0.06 | Why? |
| Malawi | 1 | 2021 | 287 | 0.05 | Why? |
| Students | 1 | 2019 | 5255 | 0.05 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.05 | Why? |
| Vaccines, Acellular | 1 | 2019 | 12 | 0.05 | Why? |
| Disk Diffusion Antimicrobial Tests | 1 | 2019 | 36 | 0.05 | Why? |
| Bacterial Outer Membrane Proteins | 1 | 2019 | 60 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Vaccines | 1 | 2018 | 3692 | 0.05 | Why? |
| Neuropilin-1 | 1 | 2021 | 284 | 0.05 | Why? |
| Parainfluenza Virus 2, Human | 1 | 2017 | 52 | 0.04 | Why? |
| Parainfluenza Virus 1, Human | 1 | 2017 | 71 | 0.04 | Why? |
| Toll-Like Receptor 7 | 1 | 2021 | 402 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2021 | 243684 | 0.04 | Why? |
| Nasopharynx | 1 | 2017 | 10224 | 0.04 | Why? |
| Tetanus Toxoid | 1 | 2018 | 136 | 0.04 | Why? |
| Ciprofloxacin | 1 | 2018 | 130 | 0.04 | Why? |
| Genes, Bacterial | 1 | 2018 | 207 | 0.04 | Why? |
| Bacterial Typing Techniques | 1 | 2018 | 273 | 0.04 | Why? |
| Risk | 2 | 2020 | 5288 | 0.04 | Why? |
| Molecular Typing | 1 | 2018 | 280 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.04 | Why? |
| Research Report | 1 | 2020 | 376 | 0.04 | Why? |
| Ceftriaxone | 1 | 2018 | 365 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Quality Control | 1 | 2019 | 628 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Information Dissemination | 2 | 2020 | 2986 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Hot Temperature | 1 | 2020 | 1299 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 1439 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.03 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.03 | Why? |
| Nasal Cavity | 1 | 2017 | 909 | 0.03 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.03 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.03 | Why? |
| Rhinovirus | 1 | 2017 | 979 | 0.03 | Why? |
| Communicable Disease Control | 2 | 2018 | 29620 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2017 | 846 | 0.03 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.02 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Mass Media | 1 | 2017 | 837 | 0.02 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Laboratories | 1 | 2019 | 2858 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.02 | Why? |
| Azithromycin | 1 | 2018 | 3943 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| Global Health | 1 | 2019 | 13911 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |